Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-(4-(4'-pyridyl)aminophenyl)-4,5-dihydro-3(2h)-pyridazinone Hydrochloride
2. Mci 154
3. Mci-154
1. 98326-33-1
2. Mci-154
3. Mci 154
4. Senazodan Hcl
5. Senazodan (hydrochloride)
6. 8aqj5mim3p
7. 6-(4-(pyridin-4-ylamino)phenyl)-4,5-dihydropyridazin-3(2h)-one Hydrochloride
8. Unii-8aqj5mim3p
9. 6-(4-(4'-pyridyl)aminophenyl)-4,5-dihydro-3(2h)-pyridazinone Hydrochloride
10. Chembl543966
11. Dtxsid00913328
12. Hy-101693a
13. 3(2h)-pyridazinone, 4,5-dihydro-6-(4-(4-pyridinylamino)phenyl)-, Monohydrochloride
14. 4,5-dihydro-6-(4-(4-pyridinylamino)phenyl)-3(2h)-pyridazinone Monohydrochloride
15. Cs-0033842
16. Q27270120
17. 3-[4-(pyridin-4-ylamino)phenyl]-4,5-dihydro-1h-pyridazin-6-one;hydrochloride
18. 3(2h)-pyridazinone, 4,5-dihydro-6-(4-(4-pyridinylamino)phenyl)-, Hydrochloride (1:1)
19. 6-{4-[(pyridin-4(1h)-ylidene)amino]phenyl}-4,5-dihydropyridazin-3-ol--hydrogen Chloride (1/1)
Molecular Weight | 302.76 g/mol |
---|---|
Molecular Formula | C15H15ClN4O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 302.0934388 g/mol |
Monoisotopic Mass | 302.0934388 g/mol |
Topological Polar Surface Area | 66.4 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 368 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?